Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline

J Endocrinol Invest. 2014 Oct;37(10):1017-30. doi: 10.1007/s40618-014-0146-x. Epub 2014 Sep 23.
No abstract available

MeSH terms

  • Acromegaly / drug therapy*
  • Endocrinology / standards*
  • Human Growth Hormone / administration & dosage
  • Human Growth Hormone / adverse effects
  • Human Growth Hormone / analogs & derivatives*
  • Human Growth Hormone / pharmacology
  • Humans
  • Italy
  • Practice Guidelines as Topic / standards*
  • Receptors, Somatotropin / antagonists & inhibitors*

Substances

  • Receptors, Somatotropin
  • Human Growth Hormone
  • pegvisomant